Please assess the completion status of the following clinical trial:

Trial Title: Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Veteran organ transplant recipients will be identified using International Classification of Diseases (ICD) 9/10 codes from the VA electronic health record (CPRS).~* Patients must have an active code stating they are a recipient of an organ transplant.~* The following codes will be utilized - ICD-9 codes:~  * V42.0~ * V42.1~ * V42.6~ * V42.7~ * V42.83~ * V42.84~ * 996.81~ * 996.82~ * 996.83~ * 996.84~ * 996.86~ * 52.80~OR~* oICD-10 codes:~  * C80.2~ * T86.1~ * T86.10~ * T86.11~ * T86.12~ * T86.13~ * T86.19~ * T86.2~ * T86.20~ * T86.21~ * T86.22~ * T86.23~ * T86.290~ * T86.298~ * T86.3~ * T86.30~ * T86.31~ * T86.32~ * T86.33~ * T86.39~ * T86.4~ * T86.40~ * T86.41~ * T86.42~ * T86.43~ * T86.49~ * T86.810~ * T86.811~ * T86.812~ * T86.818~ * T86.819~ * T86.9~ * Z48.2~ * Z48.21~ * Z48.22~ * Z48.23~ * Z48.24~ * Z48.280~ * Z48.288~ * Z48.298~ * Z94.0~ * Z94.1~ * Z94.2~ * Z94.3~ * Z94.4~ * Z94.83~AND~* Actively receiving at least one anti-rejection medication dispensed by the VA site.~* These medications include:~  * tacrolimus~ * cyclosporine~ * azathioprine~ * mycophenolate~ * sirolimus~ * everolimus~ * belatacept~Exclusion Criteria:~* There are no exclusion criteria for patients in this study as recruitment is at the level of the VA site.~* All veterans meeting inclusion criteria will be monitored by the dashboard system and will be included in the outcomes assessment.~* Patients may enter or exit the study in a rolling manner, which will be accounted for during analyses.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Arm (Type: NO_INTERVENTION): Usual Care
- Intervention Arm (Type: EXPERIMENTAL): Technology-enabled pharmacist intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).